Growing evidence along with rapidly developing genome editing and omics techniques are likely to revolutionize new roles and autophagic activities of different mutant p53 proteins that may vary according to changes within tumors or in the tumor microenvironment. This evidence concerns the gene TP53 and neoplasm.